Prothena (NASDAQ:PRTA – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research note issued to investors on Friday,Benzinga reports. They ...
Investment analysts at StockNews.com began coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a research note issued on Sunday. The brokerage set a “sell” rating on the specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback